Ameriprise
BDSI

Ameriprise’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Ameriprise’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-478,603
Closed -$2.23M – 3844
2019
Q2 		$2.23M Sell
478,603
-245,842
-34% -$1.14M ﹤0.01% 2684
2019
Q1 		$3.84M Sell
724,445
-365,895
-34% -$1.67M ﹤0.01% 2394
2018
Q4 		$4.03M Sell
1,090,340
-45,856
-4% -$161K ﹤0.01% 2263
2018
Q3 		$3.18M Buy
1,136,196
+22,400
+2% +$62.9K ﹤0.01% 2617
2018
Q2 		$3.29M Sell
1,113,796
-200,705
-15% -$476K ﹤0.01% 2501
2018
Q1 		$2.96M Buy
1,314,501
+6,700
+0.5% +$15.7K ﹤0.01% 2516
2017
Q4 		$3.86M Sell
1,307,801
-122,450
-9% -$339K ﹤0.01% 2303
2017
Q3 		$4.22M Sell
1,430,251
-464,816
-25% -$1.42M ﹤0.01% 2211
2017
Q2 		$5.31M Sell
1,895,067
-479,308
-20% -$1.01M ﹤0.01% 2029
2017
Q1 		$4.51M Sell
2,374,375
-769,362
-24% -$1.48M ﹤0.01% 2120
2016
Q4 		$5.5M Buy
3,143,737
+1,440,380
+85% +$2.94M ﹤0.01% 1967
2016
Q3 		$4.6M Buy
1,703,357
+812,089
+91% +$2.06M ﹤0.01% 2059
2016
Q2 		$2.1M Buy
+891,268
New +$2.46M ﹤0.01% 2499
2015
Q3 		– Sell
-25,480
Closed -$203K – 4183
2015
Q2 		$203K Sell
25,480
-72,990
-74% -$627K ﹤0.01% 3834
2015
Q1 		$1.03M Sell
98,470
-97,647
-50% -$1.33M ﹤0.01% 2937
2014
Q4 		$2.36M Buy
196,117
+20,174
+11% +$307K ﹤0.01% 2493
2014
Q3 		$3.01M Buy
175,943
+35,865
+26% +$521K ﹤0.01% 2325
2014
Q2 		$1.69M Buy
140,078
+3,104
+2% +$29.4K ﹤0.01% 2588
2014
Q1 		$1.16M Buy
+136,974
New +$1.11M ﹤0.01% 2673
2013
Q4 		– Sell
-1,865
Closed -$10K – 5903
2013
Q3 		$10K Hold
1,865
– – ﹤0.01% 4949
2013
Q2 		$8K Buy
+1,865
New +$8.75K ﹤0.01% 4969

Other funds holding BDSI

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Ameriprise's BDSI Position: Q3 2019 in Review

Ameriprise sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2019, closing a stake of 478,603 shares — an estimated $2.23M sold.

Ameriprise first reported a position in BDSI in Q2 2013 and held it in 21 quarters. The position peaked at $5.5M in Q4 2016. 119 funds tracked by Wall St. Rank hold BDSI as of Q3 2019.

  • Ameriprise reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2019 after selling out during the quarter.
  • Ameriprise sold 478,603 BioDelivery Sciences International, Inc. shares in Q3 2019, an estimated $2.23M.
  • Ameriprise first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 21 quarters.
  • Ameriprise's BioDelivery Sciences International, Inc. position peaked at $5.5M in Q4 2016.
  • 119 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2019.

Based on Ameriprise's 13F filing for Q3 2019, filed 14 Nov 2019.